Pfizer and BioNTech say vaccine prevents Covid-19 in adolescents

Pfizer and BioNTech said Wednesday that their Covid-19 vaccine prevented symptomatic disease and was well-tolerated in a Phase 3 study of adolescents ages 12 to 15.

The companies say they will submit the data to the Food and Drug Administration as an amendment to the vaccine’s emergency use authorization, and will also submit the results to other regulators around the world.

Read the rest…

Read Original Article: Pfizer and BioNTech say vaccine prevents Covid-19 in adolescents »